# MEDIHONEY® Gel Versus Collagenase for Wound Debridement

> **NCT02482948** · NA · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 10 (actual)

## Conditions studied

- Ulcer
- Wounds

## Interventions

- **DEVICE:** Active Leptospermum Honey (Medihoney)
- **DRUG:** Collagenase

## Key facts

- **NCT ID:** NCT02482948
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Poor enrollment.
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482948, "MEDIHONEY® Gel Versus Collagenase for Wound Debridement". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02482948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*